(Press-News.org) Washington, DC, 22 October 2010 — Autism was described as early as 1940, but a marked increase in the prevalence for the broader class of autism spectrum disorders (ASDs) during the past decade highlights the demand for treatment of affected individuals. The Centers for Disease Control and Prevention (CDC) reported that the prevalence of ASD was one in 110 children in 2006 and increased at an average annual rate of 57% between 2002 and 2006.1 The rising prevalence has heightened concern about the financial impact of treating ASDs in the private and public health care systems.[1]
The escalating health care expenditures associated with autism spectrum disorders (ASDs) in state Medicaid programs is the subject of a study by Penn State College of Medicine researchers in the November issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP).[2]
In the article titled "Health Care Expenditures for Children with Autism Spectrum Disorders in Medicaid," Drs. Li Wang and Douglas Leslie used Medicaid data from 42 states from 2000 to 2003, to evaluate costs for patients aged 17 years and under who were continuously enrolled in fee-for-service Medicaid. Total expenditures included Medicaid reimbursements from inpatient, outpatient, and long-term care, as well as prescription drugs, for each treated patient.
During the study period over two million children were diagnosed with some type of mental disorder. Of these children, nearly 70,000 had an ASD, with approximately 50,000 having autism. Researchers found that total health care expenditures per child with ASD were $22,079 in 2000 (in 2003 US dollars), and rose by 3.1% to $22,772 in 2003.
Strikingly, the increase in the treated prevalence of autism was higher than in any other mental disorder, rising by 32.2% from 40.6 to 53.6 per 10,000 covered lives. Total health care expenditures for ASDs per 10,000 covered lives grew by 32.8% from $1,270,435 in 2000 (in 2003 dollars) to a remarkable $1,686,938 in 2003.
ASDs are known to occur in all ethnic and socioeconomic groups and are characterized by impaired social interaction. Symptoms can improve with age, although many individuals continue to need support into adulthood.[3]
This study is the first to use recent national Medicaid data to estimate ASD-related health care expenditures. Medicaid expenditures per ASD child are much higher than those reported for privately insured children.[4] The rapid rise in the Medicaid expenditures for ASDs is largely due to the increase of treated prevalence rather than an increase in per patient expenditures.
In conclusion, Wang and Leslie state, "Efforts should be made to ensure that adequate resources are in place to reduce barriers to care for this particularly vulnerable population."
INFORMATION:
This study was funded by a grant from the National Institute of Mental Health to Dr. Leslie.The study is published in the Journal of the American Academy of Child and Adolescent Psychiatry and online at www.jaacap.org.
Notes to Editors:
You may contact the author, Dr. Li Wang at lwang@hes.hmc.psu.edu . For further information, please contact Rebecca Jensen, Managing Editor, JAACAP, rjensen@jaacap.org or 202.966.7300 x 112.
About the Journal of the American Academy of Child and Adolescent Psychiatry
The Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families.
The Journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The Journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
[1]Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/ncbddd/features/counting-autism.html.
[2]. Wang L , Leslie DL. Health Care Expenditures for Children With Autism Spectrum Disorders in Medicaid. Journal of the American Academy of Child and Adolescent Psychiatry. 2010;49(11):1165�.
[3]Autism Fact Sheet. www.ninds.nih.gov/disorders/autism/detail_autism.htm. Accessed October 9, 2010.
[4]Leslie DL, Martin A. Health Care Costs Associated with Autism-Spectrum Disorders. Archives of Pediatrics and Adolescent Medicine 2007;161(4):350-355.
A variant of last year's pandemic influenza linked to fatal cases carried a mutation that enabled it to infect a different subset of cells lining the airway, according to new research. The study, due to be published next week in the Journal of Virology, suggests that the mutant virus could have impaired the lungs' ability to clear out germs. The researchers behind the study, from Imperial College London, the Medical Research Council National Institute for Medical Research and the University of Marburg said the findings highlight the potential for deadlier strains of flu ...
BOSTON—Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.
Parents who had agreed to their children's enrollment in treatment trials said they felt hurried in making the decision, the researchers said. They also perceived themselves ...
The bankers who brought the global economy to its knees two years ago may have enjoyed the sensation of losing hundreds of billions of pounds and plunging the world into recession, according to an academic at Cardiff University.
In an article published in Angelaki: Journal of the Theoretical Humanities, Dr Paul Crosthwaite claims that the willingness of banks to deal in sub-prime loans and related derivatives, which were bound to result in disastrous losses, can only be understood if the bankers unconsciously desired the destruction of their own institutions. Such catastrophic ...
Since September 1st, 2009 the sale and import of incandescent light bulbs – more accurately known as tungsten filament bulbs – with the lowest energy efficiency classifications F and G have been banned in Switzerland. In addition, on the same day this country also adopted the EU's incandescent light bulb ban, which legislates for a step-by-step phasing-out of these inefficient light sources. In accordance with the new EU rules, 100 Watt bulbs were banned on September 1st, 2009, and a year later all bulbs rated between 75 and 100 Watts will be withdrawn from the market. ...
When the gap between the haves and have-nots gets larger, one would think the have-nots would want more help, most likely in the form of government programs, to fight rising inequities.
Not so, says Nate Kelly, assistant professor of political science at the University of Tennessee, Knoxville.
Kelly, along with Peter Enns of Cornell University, conducted a study analyzing economic inequality and public opinion toward government intervention. The study has been published in the October edition of the American Journal of Political Science and can be viewed by visiting ...
Princeton scientists have identified genes responsible for controlling reproductive life span in worms and found they may control genes regulating similar functions in humans.
The work suggests that someday researchers may be able to develop ways to maintain fertility in humans, allowing women who want to delay having children to preserve that capacity and extend their reproduction, and to prevent maternal age-related birth defects.
The research, led by Coleen Murphy, an assistant professor of molecular biology and the Lewis-Sigler Institute for Integrative Genomics, ...
Today´s 70-year-olds do far better in intelligence tests than their predecessors. It has also become more difficult to detect dementia in its early stages, though forgetfulness is still an early symptom, reveals new research from the University of Gothenburg, Sweden, based on the H70 study.
The H70 study provides data on cognitive symptoms that researchers have used to predict the development of dementia, and also to investigate whether the symptoms have changed in recent generations. The study involves a large proportion of 70-year-olds from Gothenburg, Sweden, who have ...
WORCESTER, Mass. – With a failure rate as high as 50 percent, bone tissue grafts pose a significant obstacle to orthopedic surgeons attempting to repair complex fractures or large areas of bone loss, such as those often caused by trauma and cancer. Current synthetic substitutes rarely possess the bone-like properties needed for successful grafting and are often difficult for surgeons to manipulate in the operating room. In response to these challenges, researchers at UMass Medical School have developed an easy-to-produce, inexpensive, synthetic bone material called FlexBone. ...
U.S. Department of Agriculture (USDA) scientists are developing vaccines to help protect healthy farm-raised catfish against key diseases.
Working as a team, microbiologist Phillip H. Klesius and molecular biologists Julia Pridgeon and Craig Shoemaker with USDA's Agricultural Research Service (ARS) at the agency's Aquatic Animal Health Research Unit in Auburn, Ala., and Joyce J. Evans, aquatic pathologist at the Auburn unit's lab in Chestertown, Md., are developing vaccines against Streptococcus iniae, S. agalactiae and other pathogens.
ARS is USDA's principal intramural ...
Succimer, a drug used for treating lead poisoning, does not effectively remove mercury from the body, according to research supported by the National Institutes of Health. Some families have turned to succimer as an alternative therapy for treating autism.
"Succimer is effective for treating children with lead poisoning, but it does not work very well for mercury," said Walter Rogan, M.D., head of the Pediatric Epidemiology Group at the National Institute of Environmental Health Sciences (NIEHS), part of NIH, and an author on the paper that appears online in the Journal ...
